vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and HCI Group, Inc. (HCI). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $242.9M, roughly 1.1× HCI Group, Inc.). HCI Group, Inc. runs the higher net margin — 35.0% vs -14.3%, a 49.3% gap on every dollar of revenue. On growth, HCI Group, Inc. posted the faster year-over-year revenue change (12.2% vs 4.7%). Over the past eight quarters, HCI Group, Inc.'s revenue compounded faster (8.5% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
HCI Equity Partners is a Washington, DC–based private equity firm with an additional office in Chicago, Illinois.
EHAB vs HCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $242.9M |
| Net Profit | $-38.7M | $85.0M |
| Gross Margin | — | — |
| Operating Margin | -12.3% | — |
| Net Margin | -14.3% | 35.0% |
| Revenue YoY | 4.7% | 12.2% |
| Net Profit YoY | 15.9% | 14.6% |
| EPS (diluted) | $-0.76 | $5.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $242.9M | ||
| Q4 25 | $270.4M | $246.2M | ||
| Q3 25 | $263.6M | $216.3M | ||
| Q2 25 | $266.1M | $221.9M | ||
| Q1 25 | $259.9M | $216.4M | ||
| Q4 24 | $258.2M | $161.9M | ||
| Q3 24 | $253.6M | $175.3M | ||
| Q2 24 | $260.6M | $206.2M |
| Q1 26 | — | $85.0M | ||
| Q4 25 | $-38.7M | $97.7M | ||
| Q3 25 | $11.1M | $65.5M | ||
| Q2 25 | $5.2M | $66.2M | ||
| Q1 25 | $17.8M | $69.7M | ||
| Q4 24 | $-46.0M | $2.6M | ||
| Q3 24 | $-110.2M | $5.7M | ||
| Q2 24 | $-200.0K | $54.1M |
| Q1 26 | — | — | ||
| Q4 25 | -12.3% | 58.5% | ||
| Q3 25 | 6.4% | 41.9% | ||
| Q2 25 | 6.3% | 42.5% | ||
| Q1 25 | 6.1% | 46.4% | ||
| Q4 24 | -16.0% | 3.6% | ||
| Q3 24 | -38.6% | 8.0% | ||
| Q2 24 | 4.3% | 36.9% |
| Q1 26 | — | 35.0% | ||
| Q4 25 | -14.3% | 39.7% | ||
| Q3 25 | 4.2% | 30.3% | ||
| Q2 25 | 2.0% | 29.8% | ||
| Q1 25 | 6.8% | 32.2% | ||
| Q4 24 | -17.8% | 1.6% | ||
| Q3 24 | -43.5% | 3.2% | ||
| Q2 24 | -0.1% | 26.2% |
| Q1 26 | — | $5.45 | ||
| Q4 25 | $-0.76 | $7.29 | ||
| Q3 25 | $0.22 | $4.90 | ||
| Q2 25 | $0.10 | $5.18 | ||
| Q1 25 | $0.35 | $5.35 | ||
| Q4 24 | $-0.92 | $0.32 | ||
| Q3 24 | $-2.20 | $0.52 | ||
| Q2 24 | $0.00 | $4.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $1.0B |
| Total DebtLower is stronger | $426.0M | $31.7M |
| Stockholders' EquityBook value | $534.0M | $1.1B |
| Total Assets | $1.2B | $2.6B |
| Debt / EquityLower = less leverage | 0.80× | 0.03× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.0B | ||
| Q4 25 | $43.6M | $1.2B | ||
| Q3 25 | $56.9M | $987.9M | ||
| Q2 25 | $37.1M | $947.2M | ||
| Q1 25 | $39.5M | $754.5M | ||
| Q4 24 | $28.4M | $532.5M | ||
| Q3 24 | $45.7M | $518.8M | ||
| Q2 24 | $28.5M | $445.8M |
| Q1 26 | — | $31.7M | ||
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $534.0M | $1.0B | ||
| Q3 25 | $566.8M | $821.8M | ||
| Q2 25 | $552.4M | $758.6M | ||
| Q1 25 | $543.2M | $522.7M | ||
| Q4 24 | $523.5M | $453.3M | ||
| Q3 24 | $566.1M | $455.3M | ||
| Q2 24 | $674.3M | $447.3M |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $1.2B | $2.5B | ||
| Q3 25 | $1.2B | $2.3B | ||
| Q2 25 | $1.2B | $2.4B | ||
| Q1 25 | $1.2B | $2.3B | ||
| Q4 24 | $1.2B | $2.2B | ||
| Q3 24 | $1.3B | $2.0B | ||
| Q2 24 | $1.4B | $1.9B |
| Q1 26 | — | 0.03× | ||
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | — |
| Free Cash FlowOCF − Capex | $3.3M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.4M | $444.4M | ||
| Q3 25 | $37.8M | $26.7M | ||
| Q2 25 | $10.6M | $145.0M | ||
| Q1 25 | $17.9M | $162.0M | ||
| Q4 24 | $-4.1M | $331.8M | ||
| Q3 24 | $28.4M | $104.1M | ||
| Q2 24 | $9.6M | $-29.0M |
| Q1 26 | — | — | ||
| Q4 25 | $3.3M | $440.8M | ||
| Q3 25 | $36.2M | $25.9M | ||
| Q2 25 | $8.7M | $144.5M | ||
| Q1 25 | $17.6M | $160.3M | ||
| Q4 24 | $-4.7M | $327.8M | ||
| Q3 24 | $27.7M | $103.2M | ||
| Q2 24 | $8.9M | $-30.1M |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 179.0% | ||
| Q3 25 | 13.7% | 12.0% | ||
| Q2 25 | 3.3% | 65.1% | ||
| Q1 25 | 6.8% | 74.1% | ||
| Q4 24 | -1.8% | 202.5% | ||
| Q3 24 | 10.9% | 58.9% | ||
| Q2 24 | 3.4% | -14.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 1.5% | ||
| Q3 25 | 0.6% | 0.4% | ||
| Q2 25 | 0.7% | 0.2% | ||
| Q1 25 | 0.1% | 0.8% | ||
| Q4 24 | 0.2% | 2.5% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.3% | 0.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.55× | ||
| Q3 25 | 3.41× | 0.41× | ||
| Q2 25 | 2.04× | 2.19× | ||
| Q1 25 | 1.01× | 2.32× | ||
| Q4 24 | — | 128.41× | ||
| Q3 24 | — | 18.33× | ||
| Q2 24 | — | -0.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
HCI
Segment breakdown not available.
